**To the Editor**We read with interest the article entitled: "Hydrocele due to a *Wuchereria bancrofti* infection" by Takaya, et al. in Internal Medicine Advance Publication on November 19, 2018 ([@B1]). These impressive pictures of both a Giemsa-stained smear of the peripheral blood showing *Wuchereria bancrofti* and the ultrasonography findings of the hydrocele revealing dilated lymphatic vessels and adult worms are an important reminder of the need to make a differential diagnosis between hydrocele and this extremely rare disease in developed countries.

The authors described treating the case with diethylcarbamazine, which was successful and resulted in a remarkable decrease in the microfilarial count in the peripheral blood. However, we would like to note that the first-line treatment of adult worm infection should be a regimen containing albendazole, ivermectin, or doxycycline ([@B2]-[@B4]). While we understand that the patient was going to be treated for hydrocele in his native country, we believe that the anti-filarial treatment administered to this case may have been both inappropriate and insufficient in this particular instance.
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